INDIVIDUALIZATION OF CYCLOSPORINE THERAPY USING PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS

被引：389

作者：

KAHAN, BD

机构：

来源：

TRANSPLANTATION | 1985年 / 40卷 / 05期

关键词：

D O I：

10.1097/00007890-198511000-00001

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：457 / 476

页数：20

共 188 条

[1] CYCLOSPORIN-A - CORRELATION BETWEEN HPLC AND RIA SERUM LEVELS [J].

ABISCH, E ;

BEVERIDGE, T ;

GRATWOHL, A ;

NIEDERBERGER, W ;

NUSSBAUMER, K ;

SCHAUB, P ;

SPECK, B ;

TRAPP, M .

PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1982, 4 (03) :84-86

[2] EFFECTS OF INVIVO TREATMENTS WITH CYCLOSPORIN-A ON MOUSE CELL-MEDIATED IMMUNE-RESPONSES [J].

ALBERTI, S ;

BORASCHI, D ;

LUINI, W ;

TAGLIABUE, A .

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1981, 3 (04) :357-364

[3]

ALDRIDGE RD, 1985, CLIN EXP IMMUNOL, V59, P23

[4] STUDIES ON INDUCTION OF CO-BINDING PIGMENTS IN LIVER MICROSOMES BY PHENOBARBITAL AND 3-METHYLCHOLANTHRENE [J].

ALVARES, AP ;

SCHILLING, G ;

LEVIN, W ;

KUNTZMAN, R .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1967, 29 (04) :521-+

[5]

ATKINSON K, 1983, TRANSPLANTATION, V36, P590

[6]

BAXTER CR, 1982, RES COMMUN CHEM PATH, V37, P305

[7]

BENNETT W, TRANSPLANT P

[8]

BEVERIDGE T, 1981, CURR THER RES CLIN E, V30, P5

[9]

BONSER RS, 1984, LANCET, V2, P1337

[10]

BOREL JF, 1977, IMMUNOLOGY, V32, P1017

← 1 2 3 4 5 6 7 8 9 10 →